Compounds > perfluoropentane
Page last updated: 2024-08-21

perfluoropentane and Cardiac Diseases

perfluoropentane has been researched along with Cardiac Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shaw, LJ1
Abrahamson, D; Aurigemma, GP; Byrd, BF; Chrysant, SG; Cohen, JL; DeMaria, AN; Foster, E; Grayburn, PA; Hack, TC; Jacobson, SA; Kitzman, DW; Klein, AL; Klodas, E; Panza, JA; Perez, JE; Picard, MH; Raichlen, JS; Sahn, DJ; Segar, DS; Vannan, MA; Weiss, JL1

Trials

1 trial(s) available for perfluoropentane and Cardiac Diseases

ArticleYear
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:1

    Topics: Adult; Aged; Contrast Media; Echocardiography; Emulsions; Endocardium; Female; Fluorocarbons; Heart Diseases; Heart Ventricles; Humans; Injections, Intravenous; Male; Middle Aged; Sensitivity and Specificity; Single-Blind Method

1998

Other Studies

1 other study(ies) available for perfluoropentane and Cardiac Diseases

ArticleYear
Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications.
    Clinical cardiology, 1997, Volume: 20, Issue:10 Suppl 1

    Topics: Albumins; Contrast Media; Coronary Disease; Cost-Benefit Analysis; Echocardiography; Female; Fluorocarbons; Heart Diseases; Humans; Male; Myocardial Ischemia

1997